1 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
| 1 | 21729667 | Phase II trial of saracatinib (AZD0530), an oral SRC-inhibitor for the treatment of patients with hormone receptor-negative metastatic breast cancer. | 2011 Oct | 1 |